Single-Session High-Intensity Focused Ultrasound Treatment for Persistent or Relapsed Graves Disease: Preliminary Experience in a Prospective Study

医学 四分位间距 前瞻性队列研究 格雷夫斯病 甲状腺 内科学 优势比 置信区间 外科 胃肠病学
作者
Brian Hung‐Hin Lang,Yu Cho Woo,Ian Yat-Hin Wong,K.W. Chiu
出处
期刊:Radiology [Radiological Society of North America]
卷期号:285 (3): 1011-1022 被引量:27
标识
DOI:10.1148/radiol.2017162776
摘要

Purpose To evaluate the safety and efficacy of ultrasonography (US)-guided high-intensity focused ultrasound (HIFU) ablation as a treatment for medically refractory Graves disease (GD). Materials and Methods After ethics approval, a prospective trial (NCT02685514) was performed from November 2015 to February 2016. Thirty patients underwent ablation of the entire right and left thyroid lobes, with areas near the tracheal-esophageal groove and common carotid artery left unablated. Serum thyroid-stimulating hormone (TSH), free T4 (FT4), antithyroid autoantibodies, and TSH receptor (TSHR) antibody levels were evaluated afterward, and US color Doppler, US volumetry, and eye assessment were performed. The primary outcome was the 12-month relapse rate. Relapse referred to hyperthyroidism (FT4 > 23 pmol/L) afterward. Variables associated with relapse were analyzed by using binary logistic regression. Results The technical success rate was 96.7%. The cohort comprised entirely women, with a median age of 38.2 years (interquartile range, 29.5–49.0 years). After 12 months, eight patients (26.7%; 95% confidence interval [CI]: 14.19%, 44.95%) experienced relapse. One patient (3.3%; 95% CI: 0.59%, 16.67%) experienced vocal cord palsy, while two patients (6.7%; 95% CI: 1.85%, 21.33%) experienced Horner syndrome, but none of these conditions were permanent. No changes in gland volume, antithyroid autoantibody levels, and ophthalmic parameters were found at 12-month follow-up. Baseline TSHR was found to have decreased significantly at 6- and 12-month follow-up (P < .001 for both). TSHR antibody (odds ratio [OR] = 1.414; 95% CI: 1.018, 1.965; P = .039) and gland volume (OR = 0.557; 95% CI: 0.353, 0.880; P = .012) were associated with 12-month relapse, with higher antibody levels conferring a higher likelihood and smaller gland volumes conferring a lower likelihood. Conclusion US-guided HIFU of the thyroid may be a safe and efficacious treatment in patients with persistent or relapsed GD. However, further study is warranted before it can become mainstream for this indication. © RSNA, 2017 Online supplemental material is available for this article.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
tangerine完成签到,获得积分10
1秒前
忧虑的靖巧完成签到 ,获得积分0
1秒前
shengjiangtai完成签到 ,获得积分10
1秒前
victor1995888发布了新的文献求助10
2秒前
ZBH完成签到,获得积分10
3秒前
3秒前
要减肥的安柏完成签到 ,获得积分10
4秒前
5秒前
东风的应助被花花采纳,获得10
5秒前
李天王发布了新的文献求助10
5秒前
yy完成签到,获得积分10
6秒前
6秒前
6秒前
cdercder的应助被胡萝卜卜采纳,获得10
6秒前
6秒前
8秒前
LingYue发布了新的文献求助10
8秒前
勤劳的乐安完成签到,获得积分10
8秒前
8秒前
WYL发布了新的文献求助10
9秒前
李健的应助被雨季采纳,获得10
9秒前
9秒前
暴躁的店员完成签到 ,获得积分20
9秒前
SIMON发布了新的文献求助10
9秒前
FionaZhang发布了新的文献求助10
9秒前
10秒前
cdercder的应助被科研助理795采纳,获得10
11秒前
TomCat发布了新的文献求助10
11秒前
阿里卡多完成签到 ,获得积分10
12秒前
WYL发布了新的文献求助10
12秒前
WYL发布了新的文献求助10
12秒前
WYL发布了新的文献求助10
12秒前
yy发布了新的文献求助30
12秒前
桐桐的应助被xhsz1111采纳,获得10
12秒前
小赞发布了新的文献求助10
13秒前
13秒前
41651653发布了新的文献求助10
13秒前
k.o.发布了新的文献求助10
13秒前
wy发布了新的文献求助10
14秒前
飘逸小天鹅完成签到 ,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193348
求助须知:如何正确求助?哪些是违规求助? 9579548
关于积分的说明 21866040
捐赠科研通 7792906
什么是DOI,文献DOI怎么找? 3437242
关于科研通互助平台的介绍 2560702
邀请新用户注册赠送积分活动 2484066